View graph of relations
  1. 2019
  2. Published
    European Org Res Treatment Canc-Lu, Giaj-Levra, N., Giaj-Levra, M., Durieux, V., Novello, S., Besse, B., ... Berghmans, T. (2019). Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review. Journal of Thoracic Oncology, 14(12), 2053-2061. https://doi.org/10.1016/j.jtho.2019.05.037
  3. Published
  4. Published
  5. Published
  6. Published
  7. Published
  8. Published
    Alcala, N., Leblay, N., Gabriel, A. A. G., Mangiante, L., Hervas, D., Giffon, T., ... Fernandez-Cuesta, L. (2019). Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. Nature Communications, 10, 1-21. [3407]. https://doi.org/10.1038/s41467-019-11276-9
  9. Published
    Bousema, J. E., van Dorp, M., Hoeijmakers, F., Huijbregts, I. A., Barlo, N. P., Bootsma, G. P., ... van den Broek, F. J. C. (2019). Guideline adherence of mediastinal staging of non-small cell lung cancer: A multicentre retrospective analysis. Lung Cancer, 134, 52-58. https://doi.org/10.1016/j.lungcan.2019.05.031
  10. Published
  11. Published
  12. Published
  13. Published
  14. Published
  15. Published
  16. Published
  17. Published
  18. Published
  19. Published
  20. Published
  21. Published
  22. Published
  23. Published
  24. Published
  25. 2018
  26. Published
  27. Published
  28. Published
  29. Published
  30. Published
  31. Published
  32. Published
  33. Published
  34. Published
  35. Published
  36. Published
  37. Published
    Socinski, M. A., Jotte, R. M., Cappuzzo, F., Orlandi, F., Stroyakovskiy, D., Nogami, N., ... Dingemans, A-M. (2018). Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC. New England Journal of Medicine, 378(24), 2288-2301. https://doi.org/10.1056/NEJMoa1716948
  38. Published
  39. Published
  40. Published
    Vishwanathan, K., Dickinson, P. A., So, K., Thomas, K., Chen, Y-M., Carpeno, J., ... Harvey, R. D. (2018). The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib. British Journal of Clinical Pharmacology, 84(6), 1156-1169. https://doi.org/10.1111/bcp.13534
  41. Published
  42. Published
  43. Published
  44. Published
  45. Published
  46. Published
  47. Published
  48. Published
  49. Published
  50. Published
  51. Published
  52. Published
    Etop Lungscape Consortium, Kerr, K. M., Dafni, U., Schulze, K., Thunnissen, E., Bubendorf, L., ... Peters, S. (2018). Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project. Annals of Oncology, 29(1), 200-208. https://doi.org/10.1093/annonc/mdx629
  53. Published
  54. 2017
  55. Published
    Meyer, M., Vliegenthart, R., Henzler, T., Buergy, D., Giordano, F. A., Kostrzewa, M., ... Roessner, E. D. (2017). Management of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studies. Journal of Thoracic Oncology, 12(12), 1755-1765. https://doi.org/10.1016/j.jtho.2017.09.1956
  56. Published
  57. Published
  58. Published
  59. Published
  60. Published
  61. Published
  62. Published
    Derks, J. L., van Suylen, R. J., Thunnissen, E., den Bakker, M. A., Groen, H. J., Smit, E. F., ... PALGA Grp (2017). Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter? European Respiratory Journal, 49(6), [1601838]. https://doi.org/10.1183/13993003.01838-2016
  63. Published
  64. Published
  65. Published
  66. Published
  67. Published
  68. Published
  69. Published
    de Jong, E. E. C., van Elmpt, W., Hoekstra, O. S., Groen, H. J. M., Smit, E. F., Boellaard, R., ... Dingemans, A-M. C. (2017). Quality assessment of positron emission tomography scans: recommendations for future multicentre trials. Acta Oncologica, 56(11), 1459-1464. https://doi.org/10.1080/0284186X.2017.1346824
  70. 2016
  71. Published
  72. Published
  73. Published
  74. Published
  75. Published
  76. Published
  77. Published
  78. Published
  79. Published
  80. Published
  81. Published
  82. Published
  83. Published
  84. Published
  85. Published
  86. Published
  87. Published
    Dietel, M., Bubendorf, L., Dingemans, A-M. C., Dooms, C., Elmberger, G., Calero Garcia, R., ... von Laffert, M. (2016). Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group. Thorax, 71(2), 177-184. https://doi.org/10.1136/thoraxjnl-2014-206677
  88. Published
  89. Published
  90. Published
    Nilsson, R. J. A., Karachaliou, N., Berenguer, J., Gimenez-Capitan, A., Schellen, P., Teixido, C., ... Wurdinger, T. (2016). Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer. Oncotarget, 7(1), 1066-1075. https://doi.org/10.18632/oncotarget.6279
  91. Published
    Dingemans, A-M. (2016). High heels, more costs. Maastricht: Universiteit Maastricht.
  92. Published
  93. Published
  94. 2015
  95. Published
  96. Published
  97. Published
  98. Published
  99. Published
  100. Published
  101. Published
  102. Published
  103. Published
  104. Published
  105. Published
  106. Published
  107. Published
  108. Published
    Mazieres, J., Zalcman, G., Crino, L., Biondani, P., Barlesi, F., Filleron, T., ... Gautschi, O. (2015). Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort. Journal of Clinical Oncology, 33(9), 992-+. https://doi.org/10.1200/JCO.2014.58.3302
  109. Published
  110. Published
  111. Published
  112. Published
  113. Published
  114. 2014
  115. Published
  116. Published
    Peters, S., Weder, W., Dafni, U., Kerr, K. M., Bubendorf, L., Meldgaard, P., ... Stahel, R. A. (2014). Lungscape: Resected Non-Small-Cell Lung Cancer Outcome by Clinical and Pathological Parameters. Journal of Thoracic Oncology, 9(11), 1675-1684. https://doi.org/10.1097/JTO.0000000000000320
  117. Published
    Swarts, D. R. A., van Suylen, R-J., den Bakker, M. A., van Oosterhout, M. F. M., Thunnissen, F. B. J. M., Volante, M., ... Speel, E-J. M. (2014). Interobserver Variability for the WHO Classification of Pulmonary Carcinoids. American Journal of Surgical Pathology, 38(10), 1429-1436. https://doi.org/10.1097/PAS.0000000000000300
  118. Published
  119. Published
  120. Published
  121. Published
  122. Published
  123. Published
  124. Published
  125. Published
  126. Published
  127. 2013
  128. Published
  129. Published
  130. Published
  131. Published
  132. Published
  133. Published
  134. Published
  135. Published
  136. Published
  137. Published
  138. 2012
  139. Published
    Kuiper, J. L., Lind, J. S. W., Groen, H. J. M., Roder, J., Grigorieva, J., Roder, H., ... Smit, E. F. (2012). VeriStrat (R) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib. British Journal of Cancer, 107(11), 1820-1825. https://doi.org/10.1038/bjc.2012.470
  140. Published
  141. Published
  142. Published
  143. Published
  144. Published
  145. Published
  146. Published
  147. Published
  148. 2011
  149. Published
  150. Published
  151. Published
  152. Published
  153. Published
  154. Published
    Lee, J-H., Voortman, J., Dingemans, A-M. C., Voeller, D. M., Pham, T., Wang, Y., & Giaccone, G. (2011). MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer. PLOS ONE, 6(6), 8. https://doi.org/10.1371/journal.pone.0021300
  155. Published
  156. Published
  157. Published
  158. Published
  159. 2010
  160. Published
  161. Published
  162. Published
  163. Published
  164. Published
  165. Published
  166. Published
  167. Published
  168. Published